Retroperitoneal laparoscopic nephron-sparing surgery for renal tumors: report of 32 cases

Xu Zhang1, Hong-Zhao Li, Xin Ma

  • 1Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. xzhang@tjh.tjmu.edu.cn

Urology
|May 26, 2005
PubMed
Abstract

Insights

Retroperitoneal laparoscopic nephron-sparing surgery is a feasible approach for localized renal tumors. This minimally invasive technique allows for precise tumor removal, reduced recovery time, and improved cosmetic outcomes.

Area of Science:

  • Urology
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Renal tumors require effective treatment while preserving kidney function.
  • Nephron-sparing surgery is preferred for localized renal masses.
  • Laparoscopic approaches offer potential benefits over open surgery.

Purpose of the Study:

  • To assess the feasibility of retroperitoneal laparoscopic nephron-sparing surgery for renal tumors.
  • To evaluate the clinical efficacy and outcomes of this minimally invasive technique.

Main Methods:

  • Retrospective analysis of 32 patients undergoing retroperitoneal laparoscopic nephron-sparing surgery (June 2002-February 2004).
  • Procedures included tumor enucleation or wedge resection using a harmonic scalpel.
  • Follow-up included renal spiral computed tomography to assess outcomes.

Main Results:

  • All 32 procedures were technically successful with no intraoperative complications.
  • Mean operative times were 70 minutes (enucleation) and 96 minutes (wedge resection).
  • Mean blood loss was 35 mL (enucleation) and 65.5 mL (wedge resection), with a mean hospital stay of 6.5 days. Pathologic examination confirmed renal cell carcinoma (21 patients) or angiomyolipoma (11 patients), all with negative surgical margins. Mean follow-up of 13 months showed no local recurrence or metastasis.

Conclusions:

  • Retroperitoneal laparoscopic nephron-sparing surgery is a feasible and effective option for localized renal tumors.
  • The procedure enables precise tumor excision with minimal morbidity.
  • Benefits include improved cosmesis and shorter convalescence compared to traditional methods.